IMU 1.89% 5.2¢ imugene limited

Ann: Imugene onCARlytics Doses First Patient in IV Combination, page-124

  1. 1,074 Posts.
    lightbulb Created with Sketch. 452
    NThe points I have noted previously in a hypothetical case for cf33 lacking efficacy are:

    1. producing no further objective responses beyond first three depsite 47 patients dosed at last update.
    2. recruitment seemingly slowing down massively.

    Evidence for one side, so far not much for the other.

    All hypothetical of course.



 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.